Ufp Technologies (UFPT) Cash from Investing Activities (2010 - 2026)

Ufp Technologies (UFPT) posted Cash from Investing Activities of -$1.7 million for Q1 2026, up 56.22% on a QoQ basis from -$3.9 million in Q4 2025, and up 40.08% year-over-year from -$1.2 million in Q1 2025.

Ufp Technologies (UFPT) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Ufp Technologies' Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$1.7 million for Q1 2026.

  • Quarterly Cash from Investing Activities rose 40.08% year-over-year to -$1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$26.5 million (up 87.47% YoY) and the FY2025 annual result came in at -$27.6 million, up 86.87% from the prior year.
  • Cash from Investing Activities was -$1.7 million for Q1 2026 at Ufp Technologies, up from -$3.9 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $33.4 million in Q3 2022 and bottomed at -$197.2 million in Q3 2024.
  • A 5-year average of -$14.6 million and a median of -$3.0 million in 2022 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities soared 3560.93% — and 2024, when it tumbled 6979.61%.
  • Ufp Technologies' Cash from Investing Activities stood at -$3.0 million in 2022, then advanced by 7.02% to -$2.8 million in 2023, then slumped by 40.93% to -$3.9 million in 2024, then gained by 0.72% to -$3.9 million in 2025, then soared by 56.22% to -$1.7 million in 2026.
  • Business Quant data shows UFPT's Cash from Investing Activities at -$1.7 million in Q1 2026, -$3.9 million in Q4 2025, and -$15.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 183.58 Bn 176.28 Bn 6.27 Bn -20.32 Bn
2 Stryker 129.01 Bn 126.13 Bn 3.81 Bn -185.00 Mn
3 Medtronic 108.52 Bn 99.30 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 68.67 Bn 67.22 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.33 Bn 44.66 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.34 Bn 27.23 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 28.07 Bn 25.79 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.89 Bn 26.31 Bn - -
9 Koninklijke Philips 24.12 Bn 21.00 Bn 2.07 Bn -475.32 Mn
10 Ufp Technologies 1.90 Bn 1.88 Bn 44.36 Mn -1.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.69 Mn
Mar 31, 2026 -1.69 Mn
Dec 31, 2025 -3.86 Mn
Dec 31, 2025 -3.86 Mn
Sep 30, 2025 -15.27 Mn
Sep 30, 2025 -15.27 Mn
Jun 30, 2025 -5.65 Mn
Jun 30, 2025 -5.65 Mn
Mar 31, 2025 -2.82 Mn
Mar 31, 2025 -2.82 Mn
Dec 31, 2024 -3.88 Mn
Dec 31, 2024 -3.88 Mn
Sep 30, 2024 -197.17 Mn
Sep 30, 2024 -197.17 Mn
Jun 30, 2024 -7.38 Mn
Jun 30, 2024 -7.38 Mn
Mar 31, 2024 -1.73 Mn
Mar 31, 2024 -1.73 Mn
Dec 31, 2023 -2.76 Mn
Dec 31, 2023 -2.76 Mn